BRNS

0.655

3.15% 0.02

Pre-mercato: .73 0.075 +11.45%

Barinthus Biotherapeutics Plc Adr (BRNS)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

$0.635

Aprire:

$0.64

Volume 24 ore:

17,568

Relative Volume:

0.46

Capitalizzazione di mercato:

$26.76M

Reddito:

$15.12M

Utile/perdita netta:

$-66.69M

Rapporto P/E:

-0.3977

EPS:

-1.647

Flusso di cassa netto:

$-48.13M

1 W Prestazione:

+7.38%

1M Prestazione:

+9.17%

6M Prestazione:

-41.52%

1 anno Prestazione:

-31.77%

Intervallo 1D:

$0.63

$0.67

Intervallo di 1 settimana:

$0.59

$0.671

Portata 52W:

$0.512

$2.92

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile

Nome

Barinthus Biotherapeutics Plc Adr

Settore

Healthcare (1106)

Industria

Biotechnology (615)

Telefono

44 (0) 1865 818808

Indirizzo

20400 CENTURY BLVD, GERMANTOWN

Dipendente

Cinguettio

Prossima data di guadagno

2026-05-06

Ultimi documenti SEC

BRNS's Discussions on Twitter

Compare BRNS vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BRNS Barinthus Biotherapeutics Plc Adr	0.655	26.76M	15.12M	-66.69M	-48.13M	-1.647
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-05-25	Iniziato	Jefferies	Buy
2021-05-25	Iniziato	Morgan Stanley	Overweight
2021-05-25	Iniziato	William Blair	Outperform
2021-05-24	Iniziato	H.C. Wainwright	Buy

Barinthus Biotherapeutics Plc Adr Borsa (BRNS) Ultime notizie

May 01, 2026

Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Sahm

May 01, 2026

Apr 30, 2026

Barinthus Biotherapeutics (NASDAQ: BRNS) cuts Q1 loss while pursuing Clywedog merger - Stock Titan

Apr 30, 2026

Mar 28, 2026

ProShares Russell 2000 Dividend Growers ETF $SMDV Shares Sold by Capital Investment Advisors LLC - Defense World

Mar 28, 2026

Mar 16, 2026

Are NSA, ULY, ESQ, BRNS Obtaining Fair Deals for their Shareholders? - Finviz

Mar 16, 2026

Mar 14, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm

Mar 14, 2026

Jan 15, 2026

Short Interest in Barinthus Biotherapeutics PLC Sponsored ADR (NASDAQ:BRNS) Grows By 72.8% - Defense World

Jan 15, 2026

BioHarvest Sciences Inc. (NASDAQ:BHST) Sees Large Increase in Short Interest - Defense World

Jan 15, 2026

Jan 03, 2026

Lowe’s Companies, Inc. $LOW Shares Acquired by Arbor Investment Advisors LLC - Defense World

Jan 03, 2026

Dec 22, 2025

Barinthus Biotherapeutics PLC sponsored ADR (BRNS) upgraded to buy: What does it mean for the stock? - MSN

Dec 22, 2025

Dec 15, 2025

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Dec 15, 2025

Should I buy Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) - zacks.com

Dec 15, 2025

Dec 10, 2025

Barinthus Bio reports positive initial data from celiac therapy trial - Investing.com India

Dec 10, 2025

Nov 20, 2025

Halper Sadeh LLC Encourages HFWA, BRNS, FITB Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.

Nov 20, 2025

HC Wainwright Has Optimistic View of BRNS FY2025 Earnings - Defense World

Nov 20, 2025

Nov 19, 2025

Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights - Finviz

Nov 19, 2025

Nov 12, 2025

Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights - Barchart.com

Nov 12, 2025

Nov 11, 2025